Home / Market News / $OMDA

$OMDA news and market catalysts

The 14 most recent market catalysts affecting $OMDA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

14 catalysts 3 high impact 10 bullish 0 bearish Healthcare Technology
Nov 7, 2026 Corporate Catalyst Neutral Impact 55
Barclays Maintains Omada Health Buy Rating, Lowers Price Target to $22
Barclays analyst Saket Kalia maintained a 'Buy' rating on Omada Health but reduced the price target from $24 to $22. This action signals that while the analyst still sees long-term…
Nov 5, 2026 Corporate Catalyst Bullish Impact 92
Omada Health Reports Third Quarter 2026 Financial Results
Omada Health announced impressive third-quarter 2026 financial results, significantly beating revenue expectations and achieving a net income of $7 million, a substantial turnaroun…
Oct 31, 2026 Corporate Catalyst Neutral Impact 75
Omda Closes Purchase of Saab's Public Safety Solutions Business
Omda AS has officially closed its acquisition of Saab's Public Safety Solutions business, as reported in this 8-K filing. This transaction is significant for Omda as it directly ex…
Oct 12, 2026 Corporate Catalyst Neutral Impact 85
Transcript: Omada Health Q2 2026 Earnings Conference Call
Omada Health's Q2 2026 earnings call transcript reveals a very strong financial quarter, with record revenue and expanded gross margins, leading to an upward revision of full-year …
Sep 11, 2026 Corporate Catalyst Bullish Impact 55
Barclays Maintains Overweight on Omada Health, Raises Price Target to $27
Barclays analyst Saket Kalia has maintained an 'Overweight' rating on Omada Health (OMDA) and raised the price target from $25 to $27. This action signals continued confidence from…
Aug 14, 2026 Corporate Catalyst Bullish Impact 60
JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30
JP Morgan analyst Lisa Gill maintained an 'Overweight' rating on Omada Health and raised the price target from $26 to $30. This indicates a strengthened positive outlook from a pro…
Aug 14, 2026 Corporate Catalyst Bullish Impact 55
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $32
Citizens analyst Constantine Davides has maintained a 'Market Outperform' rating on Omada Health (OMDA) and raised the price target from $27 to $32. This action signals increased c…
Aug 10, 2026 Corporate Catalyst Bullish Impact 55
BTIG Maintains Buy on Omada Health, Raises Price Target to $35
BTIG analyst David Larsen maintained a 'Buy' rating on Omada Health (OMDA) and raised the price target from $30 to $35. This indicates a continued bullish sentiment from the analys…
Aug 6, 2026 Corporate Catalyst Bullish Impact 75
Omada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M Est
Omada Health (OMDA) has raised its FY2026 sales guidance from $322M-$330M to $334M-$340M, significantly exceeding the analyst consensus of $327.789M. This upward revision indicates…
Aug 6, 2026 Corporate Catalyst Bullish Impact 92
Omada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M Estimate
Omada Health (OMDA) reported a substantial beat on both earnings and revenue for Q2. The company posted an EPS of $0.08, significantly exceeding the analyst consensus of a $(0.01) …
Aug 3, 2026 Corporate Catalyst Bullish Impact 55
Barclays Maintains Overweight on Omada Health, Raises Price Target to $25
Barclays analyst Saket Kalia maintaining an 'Overweight' rating and raising the price target for Omada Health from $20 to $25 is a positive signal for the company. This action sugg…
Jul 21, 2026 Corporate Catalyst Bullish Impact 55
Canaccord Genuity Maintains Buy on Omada Health, Raises Price Target to $28
Canaccord Genuity analyst Richard Close has maintained a 'Buy' rating on Omada Health (OMDA) and raised the price target from $24 to $28. This analyst action signals continued conf…
Jul 20, 2026 Corporate Catalyst Bullish Impact 55
Citizens Maintains Market Outperform on Omada Health, Raises Price Target to $27
Citizens analyst Constantine Davides has reiterated a 'Market Outperform' rating for Omada Health (OMDA) and raised the price target from $21 to $27. This action signals a strength…
Jul 17, 2026 Corporate Catalyst Neutral Impact 65
BTIG Initiates Coverage On Omada Health with Buy Rating, Announces Price Target of $30
BTIG's initiation of coverage on Omada Health with a 'Buy' rating and a $30 price target is a significant event for the company. Analyst coverage, especially with a positive rating…
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.